HomeEntertainmentVerastem stock rises on FDA fast track for lung cancer drug Verastem stock rises on FDA fast track for lung cancer drug June 3, 2026byadmin Verastem stock rises on FDA fast track for lung cancer drug Source link
Jade Biosciences prices $150 million public offering at $15 Jade Biosciences prices $150 million public offering at $15 Source link
Bath & Body Works’ SWOT analysis: stock faces turnaround test Bath & Body Works’ SWOT analysis: stock faces turnaround test Source link